13FPulse
中
AC

ACRS ACLARIS THERAPEUTICS INC

2026Q1 · CUSIP 00461U105 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
135
Δ holders QoQ
+13
Breadth percentile
Top 23%
Whale holders
77
Δ whales
+6
Inst. holding value
$406M
New positions
33
Closed positions
20
Price momentum (1Q)
+35.0%
Put / Call
2/3

Breadth history (34 quarters)

2018Q1: holders=101 2018Q2: holders=96 2018Q3: holders=87 2018Q4: holders=100 2019Q1: holders=96 2019Q2: holders=86 2019Q3: holders=81 2019Q4: holders=81 2020Q1: holders=72 2020Q2: holders=63 2020Q3: holders=58 2020Q4: holders=83 2021Q1: holders=98 2021Q2: holders=130 2021Q3: holders=127 2021Q4: holders=135 2022Q1: holders=112 2022Q2: holders=116 2022Q3: holders=129 2022Q4: holders=130 2023Q1: holders=150 2023Q2: holders=134 2023Q3: holders=139 2023Q4: holders=108 2024Q1: holders=99 2024Q2: holders=99 2024Q3: holders=82 2024Q4: holders=99 2025Q1: holders=108 2025Q2: holders=96 2025Q3: holders=103 2025Q4: holders=122 2026Q1: holders=135 -32 -16 +0 +16 +32 52105158 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 4 lit events

Period Percentile Next-1Q return Next-2Q return
2023Q1 Top 8% -13.8% -90.3%
2022Q3 Top 10% -26.9% -54.5%
2021Q2 Top 6% +9.1% -13.1%
2018Q4 Top 18% -23.5% -86.5%

Options Sentiment

Put holders
2
QoQ: +2
Call holders
3
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.56
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
-52.9%
Net margin
—
ROE
-48.5%
Debt ratio
27.7%
FCF (TTM)
-$52M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
2025-03-31: EPS -0.12 2025-06-30: EPS -0.13 2025-09-30: EPS -0.12 2025-12-31: EPS -0.16 2026-03-31: EPS -0.15 0M 10M 19M $M -0.18 -0.09 0.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.